KUALA LUMPUR, June 12 (Bernama) -- Spring Bio Solution, a global leader in comparator sourcing and clinical trial supplies, has launched NCE Grid, touted as the world’s first free new chemical entity (NCE-1) intelligence platform — built to decode, centralise, and visualise Paragraph IV (Para IV) opportunities in real-time.
In a statement, the company said the platform addresses long-standing challenges in the pharmaceutical industry, where tracking NCE exclusivity expirations and Para IV filings has been a fragmented and manual process, often relying on spreadsheets and siloed databases.
Spring Bio Solution Founder and Chief Executive Officer, Salim Shaikh said: “We created NCE Grid because we saw too many companies struggle with fragmented insights and missed opportunities.
“In a race where timing is everything, our platform brings clarity, speed, and a competitive edge to decision-makers. When you think Para IV, think NCE Grid — your trusted guide for strategic drug development.”
NCE Grid consolidates key data points, including molecule, innovator name, NCE-1 date, revenue, therapeutic applications, sales forecasts, and percentage of compound annual growth rates (CAGR), into one intuitive platform.
The platform aims to support regulatory, strategy, and portfolio teams by offering real-time insights to identify and prioritise first-to-file opportunities, a crucial factor for generic pharmaceutical companies competing for market exclusivity.
-- BERNAMA
BERNAMA provides up-to-date authentic and comprehensive news and information which are disseminated via BERNAMA Wires; www.bernama.com; BERNAMA TV on Astro 502, unifi TV 631 and MYTV 121 channels and BERNAMA Radio on FM93.9 (Klang Valley), FM107.5 (Johor Bahru), FM107.9 (Kota Kinabalu) and FM100.9 (Kuching) frequencies.
Follow us on social media :
Facebook : @bernamaofficial, @bernamatv, @bernamaradio
Twitter : @bernama.com, @BernamaTV, @bernamaradio
Instagram : @bernamaofficial, @bernamatvofficial, @bernamaradioofficial
TikTok : @bernamaofficial
